Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tremfya (guselkumab)
Marketing
AbbVie’s Skyrizi retakes top spot in April ad spend rankings
After losing the top spot in March to Johnson & Johnson’s Tremfya, AbbVie’s Skyrizi is back as the top drug by ad spending.
Ben Adams
May 8, 2026 10:03am
J&J charts speedy launch of new psoriasis pill Icotyde
Apr 14, 2026 11:43am
J&J's Tremfya retakes TV drug ad spending crown from AbbVie
Apr 8, 2026 11:44am
J&J chief Joaquin Duato collects sizable pay raise for 2025
Mar 11, 2026 10:55am
Super Bowl, Olympics defined TV drug ad spending in February
Mar 6, 2026 12:39pm
FDA untitled letter lambastes claims in ad for J&J's Tremfya
Feb 19, 2026 11:04am
